Fresenius Medical Care Reaches Analyst Target Price
December 23, 2024 at 09:30 AM EST
In recent trading, shares of Fresenius Medical Care AG (FMS) have crossed above the average analyst 12-month target price of $22.50, changing hands for $22.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..